Challenge Entries
Mar 09, 2016 / 0 Comments / in Health care
Caroline is accelerating the cost-effective development of treatment for rare diseases by addressing key translational gap and clinical development challenges, acting as an investor, a patient voice and a trusted broker between patients, pharmaceutical companies and government regulatory bodies.
Apr 09, 2014 / 0 Comments / in Medical Research, Health care, Infant health
EspeRare is accelerating the cost-effective development of unexplored treatments for rare diseases acting as a philanthropic, knowledge, and technical broker between patients, pharmaceutical industry and regulators to bring treatments for these underserved patients. With its pharma partner: Merck Serono, the foundation is enabling a dormant drug, with a high therapeutic potential for children affected by a rare incurable disease, to be developed.